Cargando…

Tisagenlecleucel for B-cell cancers

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026923/
https://www.ncbi.nlm.nih.gov/pubmed/32139961
http://dx.doi.org/10.18773/austprescr.2019.077
_version_ 1783498763457789952
collection PubMed
description
format Online
Article
Text
id pubmed-7026923
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-70269232020-03-05 Tisagenlecleucel for B-cell cancers Aust Prescr New Drugs NPS MedicineWise 2019-12-17 2020-02 /pmc/articles/PMC7026923/ /pubmed/32139961 http://dx.doi.org/10.18773/austprescr.2019.077 Text en (c) NPS MedicineWise 2020 http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Tisagenlecleucel for B-cell cancers
title Tisagenlecleucel for B-cell cancers
title_full Tisagenlecleucel for B-cell cancers
title_fullStr Tisagenlecleucel for B-cell cancers
title_full_unstemmed Tisagenlecleucel for B-cell cancers
title_short Tisagenlecleucel for B-cell cancers
title_sort tisagenlecleucel for b-cell cancers
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026923/
https://www.ncbi.nlm.nih.gov/pubmed/32139961
http://dx.doi.org/10.18773/austprescr.2019.077